Mounjaro® (tirzepatide) 2.5mg ATEOS is a once-weekly injectable prescription medicine supplied in a ready-to-use injection device. Each injection contains 2.5mg of tirzepatide in 0.5mL.
COMPOSITION
2.5mg tirzepatide /0.5mL per pen
ORIGIN
made in Japan
CONTENT
Each box contains 2 ATEOS injection devices (2 pens)
1 box = 2 weekly doses (approximately 2 weeks of treatment)
HOW TO USE
- Mounjaro® ATEOS is administered as a subcutaneous injection once a week.
- Starting dose: 2.5 mg once weekly for 4 weeks. Then normally increase to 5 mg once weekly as the maintenance dose.
- Inject once every 7 days, preferably on the same day each week.
- It can be taken with or without food.
- Follow the instructions supplied with the injection device.
- Do not inject into a vein or muscle.
- Do not share your injection device with another person.
HOW TO STORE
- Keep refrigerated at 2–8°C. Do not freeze.
- Keep in the original carton to protect from light.
- Do not use if the product has been frozen.
- If kept outside the refrigerator, store below 30°C and use within 21 days.
NOT SUITABLE FOR
Do not use Mounjaro® if you:
- Have had a serious allergic reaction to tirzepatide or any of the ingredients.
- Have type 1 diabetes.
- Have diabetic ketoacidosis, diabetic coma, or diabetic pre-coma.
- Require insulin treatment for certain serious medical conditions or emergency situations.
Speak with your doctor before using Mounjaro® if you are pregnant, planning to become pregnant, breastfeeding, or have a history of pancreatitis, severe gastrointestinal problems, or other significant medical conditions.
Important Notice
Mounjaro® is a prescription medicine and should be used under the supervision of a qualified healthcare professional.
The information provided on this page is for general product information only and does not replace professional medical advice. Always follow the dosage and instructions provided by your doctor or pharmacist.
READY STOCKS
WORLDWIDE SHIPPING
EXPRESS DELIVERY
Contact us!